(HealthDay)—Enterovirus D68 (EV-D68) detections were lower than anticipated in 2020, according to research published in the Nov. 24 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Noting that the number of EV-D68 detections followed a biennial pattern during 2014 to 2018 in the United States, Melisa M. Shah, M.D., from the CDC in Atlanta, and colleagues assessed recent levels of EV-D68. EV-D68 detections in respiratory specimens collected from patients aged
The researchers note that 382 EV-D68 detections in respiratory specimens from patients aged
“Circulation of EV-D68 in 2020 might have been limited by widespread COVID-19 mitigation measures, and changing mitigation measures might influence future EV-D68 circulation patterns,” the authors write. “Continued monitoring of EV-D68 circulation is critical to guiding clinical and public health preparedness for both EV-D68-associated ARI and acute flaccid myelitis.”
Several authors disclosed financial ties to the pharmaceutical and medical technology industries.
Anticipated increase in acute flaccid myelitis not seen in 2020
Copyright © 2021 HealthDay. All rights reserved.
Enterovirus D68 detections lower than expected in 2020 (2021, November 25)
retrieved 26 November 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.